Portfolio Companies News
September 24, 2021Targovax granted European Patent fo...
Patent protection of ONCOS-102 in combination with chemotherapy in malignant pleural mesothelioma in Europe Oslo, 24 September 2021: Targovax ASA (OSE: TRVX), a clinical stage immuno-oncology company developing immune activators to target hard-to-treat solid tumors, today announce that the... read more
September 23, 2021Strongbridge Biopharma plc Announce...
DUBLIN, Ireland and TREVOSE, Pa., Sept. 23, 2021 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc (NASDAQ: SBBP) (the “Company” or “Strongbridge”) today announced that the High Court of Ireland (the “Court”) has set the date of the final court hearing to sanction the proposed ac... read more
September 22, 2021CARISMA Therapeutics Announces U.S....
PHILADELPHIA, Sept. 22, 2021 /PRNewswire/ -- CARISMA Therapeutics Inc., a clinical stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, announced today that that the U.S. Food and Drug Administration (FDA) has granted Fast Track designatio... read more
September 22, 2021Vicore obtains SARS coronavirus pat...
Gothenburg, September 22, 2021 - Vicore Pharma Holding AB (publ) (“Vicore”), a rare disease pharmaceutical company developing innovative medicines for severe lung disorders, today announces that the U.S. Patent and Trademark Office (USPTO) has granted patent number US11,123,329 covering the use... read more
September 22, 2021Vicore to host Key Opinion Leader w...
Webinar on Thursday, September 30 @ 16:00 CET (10AM ET) with the medical doctors and IPF experts Prof. Toby Maher and Prof. Joanna Porter. Gothenburg, September 22, 2021 - Vicore Pharma Holding AB (publ) ("Vicore"), a rare disease pharmaceutical company developing innovative medicines for severe&nb... read more
July 22, 2021Q2 2021 General Market Overview
Since the start in 1996, HealthCap funds have invested in 122 portfolio companies.
46 of the portfolio companies have been taken public on nine different markets.
27 of the portfolio companies pharmaceutical products have been approved for marketing.
Since the start in 1996, HealthCap has helped build 12 companies with a valuation of USD 1 billion or more.